Solid Biosciences advances gene therapy trials across muscle diseases
Go back to Solid Biosciences advances gene therapy trials across muscle diseases| (NASDAQ: SLDB) | Delayed: 8.70 -0.37 (4.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.07 | 52 Week High | $ | |||
| Open | $9.20 | 52 Week Low | $ | |||
| Day High | $9.37 | P/E | N/A | |||
| Day Low | $8.66 | EPS | $ | |||
| Volume | 1,113,838 | |||||

